Study of patients with severe tricuspid regurgitation
Part of Heart & circulation clinical trials.
This study is collecting information about people with severe tricuspid regurgitation (a leaky heart valve) who are having a catheter-based repair. The goal is to better understand these patients and how well the procedure works for them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe tricuspid regurgitation (a leaky valve on the right side of your heart).
- You have been recommended for a catheter-based (minimally invasive) tricuspid valve procedure.
- You are not eligible for, or have not been recommended, open-heart surgery for your tricuspid valve or other heart valve problems.
- You do not have blockages in multiple heart arteries that require bypass surgery.
- You are willing to participate in this registry and give your consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with a severely leaky tricuspid heart valve who still have symptoms despite medication. It looks at outcomes after a procedure called TriClip, which helps reduce valve leakage.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This study records patients who get a catheter-based repair for a severely leaky tricuspid heart valve. It helps doctors and researchers learn how these treatments work in real-world care.
This study tests a device called TriClip to repair a leaky tricuspid valve in the heart. If the leak is reduced, you may have less shortness of breath and feel more energetic.
This study is a registry that collects data on patients who receive a new type of heart valve replacement for the tricuspid valve through a less invasive catheter procedure. Joining helps doctors learn more about how well this treatment works in real-world patients.
This study tests a new, catheter-based procedure to treat moderate-to-severe leaking of the tricuspid valve (a heart valve on the right side). It’s for people who are high surgical risk and might benefit from replacing the valve without open-heart surgery.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.